Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: Requirement for H2O2 generation

Experimental Dermatology

Volumn 13, Issue 2, 2004, Pages 78-85

  Peus, Dominik ^a   Beyerle, Astrid ^b   Vasa, Mariuca ^b   Pott, Markus ^b   Meves, Alexander ^b   Pittelkow, Mark R ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Anthralin; Epidermal growth factor receptor; Hydrogen peroxide; Keratinocytes

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACETYLCYSTEINE; ANTIOXIDANT; ANTIPSORIASIS AGENT; CATALASE; DITHRANOL; EPIDERMAL GROWTH FACTOR RECEPTOR; GALLIC ACID PROPYL ESTER; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN TYROSINE KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME;

ACETYLCYSTEINE; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CATALASE; CELLS, CULTURED; ELECTROPORATION; HUMANS; HYDROGEN PEROXIDE; KERATINOCYTES; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHOSPHOTYROSINE; PSORIASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 1342326698     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2004.00119.x     Document Type: Article

References (54)

1. Galewsky E. Über Cignolin, ein Ersatzpräperat des Chrysarobins. Dermatol Wochenschr 1916: 62: 113-115.
2. Unna P G. Cignolin als Heilmittel der Psoriasis. Dermatol Wochenschr 1916: 62: 116-137, 150-63, 175-83.
3. Mahrle G. Dithranol. Clin Dermatol 1997: 15: 723-737.
4. Reichert U, Jacques Y, Grangeret M, Schmidt R. Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes. J Invest Dermatol 1985: 84: 130-134.
5. Mrowietz U, Jessat H, Schwarz A, Schwarz T. Anthralin (dithranol) in vitro inhibits human monocytes to secrete IL-6, IL-8 and TNF-alpha, but not IL-1. Br J Dermatol 1997: 136: 542-547.
6. Schroder J M, Kosfeld U, Christophers E. Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils. J Invest Dermatol 1985: 85: 30-34.
7. Schroder J M. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils. J Invest Dermatol 1986: 87: 624-629.
8. Schmidt K N, Podda M, Packer L, Baeuerle P A. Antipsoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes. J Immunol 1996: 156: 4514-4519.
9. Finnen M J, Lawrence C M, Shuster S. Inhibition of dithranol inflammation by free-radical scavengers. Lancet 1984: 2: 1129-1130.
10. Muller K. Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals. Biochem Pharmacol 1997: 53: 1215-1221.
11. Nanney L B, Stoscheck C M, Magid M, King L E Jr. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 1986: 86: 260-265.
12. Gottlieb S L, Gilleaudeau P, Johnson R, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB:389IL:-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995: 1: 442-447.
13. Elder J T, Fisher G J, Lindquist P B, et al. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 1989: 243: 811-814.
14. Cook P W, Piepkorn M, Clegg Ch, et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Invest 1997: 100: 2286-2294.
15. Stoll S W, Elder J T. Retinoid regulation of heparin-binding EGF-like growth factor gene expression in human keratinocytes and skin. Exp Dermatol 1998: 7: 391-397.
16. Meves A, Stock S N, Beyerle A, Pittelkow M R, Peus D. H (2) O (2) mediates oxidative stress-induced epidermal growth factor receptor phosphorylation. Toxicol Lett 2001: 122: 205-214.
17. Peus D, Vasa R A, Meves A, et al. H2O2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol 1998: 110: 966-971.
18. Sundaresan M, Yu Z X, Ferrans V J, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995: 270: 296-299.
19. Rao G N. Protein tyrosine kinase activity is required for oxidant-induced extracellular signal-regulated protein kinase activation and c-fos and c-jun expression. Cell Signal 1997: 9: 181-187.
20. Rosette C, Karin M. Ultraviolet light and osmotic stress: Activation fo the JNK cascade through multiple growth factor and cytokine receptors. Science 1996: 274: 1194-1197.
21. Schieven G L, Mittler R S, Nadler S G, et al. ZAP-70 tyrosine kinase, CD45, and T cell receptor involvement in UV- and H2O2-induced T cell signal transduction. J Biol Chem 1994: 269: 20718-20726.
22. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 1998: 10: 248-253.
23. Gamou S, Shimizu N. Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor. FEBS Lett 1995: 357: 161-164.
24. Tyrrell R M. The molecular and cellular pathology of solar ultraviolet radiation. Mol Aspects Med 1994: 15: 1-77.
25. Peus D, Meves A, Vasa R A, Beyerle A, O'Brien T, Pittelkow MR. H2O2 is required for UVB-induced EGF receptor and downstream signaling pathway activation. Free Radic Biol Med 1999: 27: 1197-1202.
26. Peus D, Vasa R A, Beyerle A, Meves A, Krautmacher C, Pittelkow M R. UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J Invest Dermatol 1999: 112: 751-756.
27. Meves A, Stock S N, Beyerle A, Pittelkow M R, Peus D. Vitamin C derivative ascorbyl palmitate promotes ultraviolet-B-induced lipid peroxidation and cytotoxicity in keratinocytes. J Invest Dermatol 2002: 119: 1103-1108.
28. Richter A, Davies D E. Effects of anthralin and hypericin on growth factor signalling and cell proliferation in vitro. Biochem Pharmacol 1995: 50: 2039-2045.
29. Peus D, Hamacher L, Pittelkow M R. EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. J Invest Dermatol 1997: 109: 751-756.
30. Mohanty J G, Jaffe J S, Schulman E S, Raible D G. A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Meth 1997: 202: 133-141.
31. Karnitz L M, Sutor S L, Abraham R T. The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line. J Exp Med 1994: 179: 1799-1808.
32. Tekle E, Astumian R D, Chock P B. Electroporation by using bipolar oscillating electric field: An improved method for DNA transfection of NIH 3T3 cells. Proc Natl Acad Sci U S A 1991: 88: 4230-4234.
33. Peus D, Beyerle A, Rittner H L, et al. Anti-psoriatic drug anthralin activates JNK via lipid peroxidation: Mononuclear cells are more sensitive than keratinocytes. J Invest Dermatol 2000: 114: 688-692.
34. Fry D W, Kraker A J, McMichael A, et al. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 1994: 265: 1093-1095.
35. Stoll S, Garner W, Elder J. Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J Clin Invest 1997: 100: 1271-1281.
36. Krebs A, Schaltegger H. [Structural characteristics of tne antipsoriasic drugs chrysarobine and dithranol] Hautarzt 1969: 20: 204-209.
37. Joshi P C, Pathak M A. The role of active oxygen (1O2) and O (2) induced by crude coal tar and its ingredients used in photochemotherapy of skin diseases. J Invest Dermatol 1984: 82: 67-73.
38. Muller K. Active oxygen species and structure specificity of antipsoriatic anthrones. Arch Pharm (Weinheim) 1988: 321: 385-389.
39. Ohba M, Shibanuma M, Kuroki T, Nose K. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 1994: 126: 1079-1088.
40. Heck D E, Laskin D L, Gardner C R, Laskin J D. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 1992: 267: 21277-21280.
41. Erzurum S C, Lemarchand P, Rosenfeld M A, Yoo Jh, Crystal R G. Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucl Acids Res 1993: 21: 1607-1612.
42. Amstad P, Peskin A, Shah G, et al. The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 1991: 30: 9305-9313.
43. Bae Y S, Kang S W, Seo M S, et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 1997: 272: 217-221.
44. Knebel A, Rahmsdorf H J, Ullrich A, Herrlich P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. Embo J 1996: 15: 5314-5325.
45. Schaefer H, Schalla W, Shroot B. Anthralin-facts, trends and unresolved problems. Z Hautkr 1981: 146: 273-282.
46. Muller K, Gawlik I. Inactivation of mouse epidermal 12-lipoxygenase by anthralin - Implications for the role of oxygen radicals. Biochem Pharmacol 1996: 51: 1173-1179.
47. Zhang T, Woods T L, Elder J T. Differential responses of S100A2 to oxidative stress and increased intracellular calcium in normal, immortalized, and malignant human keratinocytes. J Invest Dermatol 2002: 119: 1196-1201.
48. Whitmarsh A J, Shore P, Sharrocks A D, Davis R J. Integration of MAP kinase signal transduction pathways at the serum response element. Science 1995: 269: 403-407.
49. Peus D, Vasa R A, Meves A, Beyerle A, Pittelkow M R. UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol 2000: 72: 135-140.
50. Stern R S. Psoriasis. Lancet 1997: 350: 349-353.
51. Gottlieb A B, Khandke L, Krane J F, Staiano-Coico L, Ashinoff R, Krueger J G. Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro. J Invest Dermatol 1992: 98: 680-685.
52. Gill G N, Lazar C S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature 1981: 293: 305-307.
53. Chin Y E, Kitagawa M, Su W C, You Zh, Iwamoto Y, Fu X Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 1996: 272: 719-722.
54. Chin Y E, Kitagawa M, Kuida K, Flavell R A, Fu X Y. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997: 17: 5328-5337.